TURBO-CANCER after COVID mRNA Vaccines. 4 International Studies highlight Lymphomas’ Risk as Serious Adverse Reactions
In the cover image, the tumor forms developed in a laboratory mouse and in a vaccinated one after Pfizer’s mRNA gene serum
by Fabio Giuseppe Carlo Carisio
The previous articles in Italian linked in this one can be read in English thanks to simultaneous translation available
Not only one but three international studies confirm the well-founded risk of tumor forms developed as adverse reactions to anti-Covid mRNA vaccines.
They add to the “historical” one published by the Head of OncoHematology of the Italian Piacenza Hospital, Professor Luigi Cavanna, in relation to the case of a 66-year-old who developed this tumor pathology only 10 days after receiving the third dose, in which, however, he reported the 8 cases of lymphomas with suspected correlation to mRNA or mDNA gene sera, already ascertained in scientific reading.
The first new research, the most disturbing, was conducted by various doctors at the University of Antwerp, in Belgium, led by Professor Sander Eens of Laboratory of Physiopharmacology, Genetics, Pharmacology and Physiopathology of Heart, Blood Vessels and Skeleton (GENCOR),
It has proven the seriously carcinogenic effects in mice: they died shortly after inoculation of the Comirnaty gene serum produced by Pfizer-Biontech without a previous verification of toxicity and carcinogenicity in clinical trials.
«Unprecedented immunization campaigns have been rolled out worldwide in an attempt to contain the ongoing COVID-19 pandemic. Multiple vaccines were brought to the market, among two utilizing novel messenger ribonucleic acid technology. Despite their undisputed success in decreasing COVID-19-associated hospitalizations and mortality, various adverse events have been reported».
This is what the Belgian researchers write in the summary of the study published in May 2023 in Frontier in Oncology and then by PubMed, the archive of the American National Institute of Health (NIH) with the title “B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: A case report”.
The Dead Mouse a few days after the Covid Vaccine
«The emergence of malignant lymphoma is one of such rare adverse events that has raised concern, although an understanding of the mechanisms potentially involved remains lacking. Herein, we present the first case of B-cell lymphoblastic lymphoma following intravenous high-dose mRNA COVID-19 vaccination (BNT162b2) in a BALB/c mouse. Two days following booster vaccination (i.e., 16 days after prime), at only 14 weeks of age, our animal suffered spontaneous death with marked organomegaly and diffuse malignant infiltration of multiple extranodal organs (heart, lung, liver, kidney, spleen) by lymphoid neoplasm» the scientists wrote.
It should be noted that these are those organs already reported by the revolutionary research of Markus Aldén and others of the Department of Clinical Sciences, Lund University, Malmö, Sweden, as the “target” of DNA alterations caused by mRNA vaccines.
The study by Sander Eens et al. continues:
«Immunohistochemical examination revealed organ sections positive for CD19, terminal deoxynucleotidyl transferase, and c-MYC, compatible with a B-cell lymphoblastic lymphoma immunophenotype. Our murine case adds to previous clinical reports on malignant lymphoma development following novel mRNA COVID-19 vaccination, although a demonstration of direct causality remains difficult. Extra vigilance is required, with conscientious reporting of similar cases and a further investigation of the mechanisms of action explaining the aforementioned association».
The Indifference of Oncologist Schillaci, Minister of Health and partner of Big Pharma
In response to these pharmacovigilance requests, the Italian Ministry of Health has already launched the new autumn vaccination campaign EVEN BEFORE the new monovalent antoCovid (approved in the USA by the FDA after the failure of the dangerous bivalent Omicron tested only on mice) has obtained the approval by the European Medicines Agency (EMA) and by the Italian Medicines Agency (AIFA).
It should be noted that the current Italian Minister of Health Orazio Schillaci, before his political appointment in the Meloni Government, was rector of the University of Rome Tor Vergata which has not only joined various projects on gene therapies and mRNA vaccines with Big Pharma but also to the Fact-Checkers censorship project financed by the European Commission, and has also personally invested in some American biomedical companies that are testing Covid gene serums in the world (Inovio) thanks to funding from Bill Gates’ NGOs (CEPI).
His indifference to the studies already published by the Piacenza Hospital and to the cases of multiple deaths from turbo-cancer of various testimonials of the vaccination campaign is unjustifiable as Schillaci boasts a specific specialization on tumor issues having been responsible for the OncoHematology division in the university hospital of the capital.
Hematological neoplasms discovered by Romanian doctors in mRNA vaccinated
«During the last two years, the COVID-19 pandemic led to millions of disease-related deaths worldwide. The efforts of the scientific community facing this global challenge resulted in outstanding achievements. Thus, within one year, new mRNA-based vaccines against SARS-CoV-2 viral infection were released, providing highly efficient protection and showing a very good safety profile in the general population».
Say some Romanian doctors in the study entitled “Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases” and published both by PubMed and by the Medicine section of the specialized journal MDPI.
The researchers, in order not to deviate from the guidelines of the scientific community, support the safety profile of gene serums which has been denied instead by the absence of specific clinical trials on genotoxicity and carcinogenicity and by an avalanche of scientific studies in various therapeutic fields.
But then they raise the alarm:
«However, clinical data collection after vaccination is a continuous process for the long-term safety of any new medical product. The aim of our paper is to present two cases of hematological malignancies: diffuse large B-cell non-Hodgkin lymphoma and T/NK-cell lymphoma, diagnosed shortly after the administration of the mRNA COVID-19 vaccine».
The research sees as first signatory Maria-Alexandra Zamfir of the Department of Oral and Maxillofacial Surgery, “Carol Davila” Central Military Emergency Hospital in Bucharest, Romania. Both cases refer to patients vaccinated with Pfizer-Biontech’s mRNA gene serum, more widespread in the European Union thanks to secret contracts (and under investigation) entered into by the President of the European Commission Ursula von Der Leyen.
Here is the conclusion:
«The safety profile of the mRNA-based vaccines is an undeniable fact. In most cases, suspicions of potentially aggressive side effects were ruled out, proving to be transient post-vaccine reactions».
Obviously, we add, except for the cases of lethal turbo-cancer that are increasing in the world among the vaccinated…
«Clinicians should remain alert to report any potentially aggressive manifestations emerging in the context of mRNA COVID-19 vaccination, such as these cases of hematological malignancies, in order to promote additional investigations on the particular mechanisms of action of COVID-19 vaccines and to provide the best medical care to the patients» conclude the Romanian scientists.
Alert from Japan: “Possible risk of malignant lymphoma after BNT162b2 mRNA vaccination”
«Although the BNT162b2 mRNA vaccine is effective, adverse effects have been reported. Here, we report a case of extranodal NK/T-cell lymphoma, nasal type (ENKL), of the left arm following BNT162b2 mRNA vaccination. A 73-year-old male presented with a lump in the left arm, which was the site where he received the BNT162b2 mRNA vaccine 3 months prior».
This is what we read in the Abstract of the study “Newly diagnosed extranodal NK/T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccination – Newly diagnosed extranodal NK/T-cell lymphoma, type nasal, left arm injected after vaccination with BNT162b2 mRNA COVID-19” published in April 2023 in PubMed and Springer by researcher Takuto Tachita of the Department of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, Aomori, Japan with other colleagues from the same university.
«He was treated with topical corticosteroids and debridement, but the tumor progressed. Additionally, fever, night sweats, and general fatigue were observed. Laboratory findings included thrombocytopenia, elevated lactate dehydrogenase, and soluble interleukin-2 receptor levels. Skin biopsy led to a diagnosis of ENKL. The patient was treated with a 50% dose of SMILE therapy and radiotherapy, resulting in regression of the tumor».
«It seems that latent Epstein-Barr virus (EBV)-infected NK/T cells were reactivated by vaccination and contributed to the onset of ENKL. This is the first report of ENKL after BNT162b2 mRNA vaccination. The present case highlights the possible risk of development of malignant lymphoma, including ENKL at the injection site, after BNT162b2 COVID-19 vaccination».
Discovered the Covid mRNA Vaccines’ Gene which may Cause Cancer. It’s the Monkey Virus DNA SV40
Also in this case the study examined a vaccine affected by a serious adverse reaction from Pfizer-Biontech’s mRNA gene serum which ended up in the eye of the storm for the 44,000 cases of neurobrain lesions that emerged from clinical trials but were carefully concealed for almost two years…
The American genomics expert Kevin MCKernano, on the other hand, has published an accurate research in which he also managed to identify what would be the biochemical component of mRNA vaccines that triggers tumor forms: the SV40 viral promoter.
Fabio Giuseppe Carlo Carisio
© COPYRIGHT GOSPA NEWS
prohibition of reproduction without authorization
follow Gospa News on Telegram
MAIN SOURCES
FRONTIERS IN ONCOLOGY – B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: A case reportMEDICINA – Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two CasesSPRINGER – Newly diagnosed extranodal NK/T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccinationGOSPA NEWS – COVID-19 DOSSIERGOSPA NEWS – WUHAN-GATES DOSSIER
Un pensiero su “TURBO-CANCER after COVID mRNA Vaccines. 4 International Studies highlight Lymphomas’ Risk as Serious Adverse Reactions”